The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
COVID-19 pandemic experience in patients with Hodgkin lymphoma.
 
Sara E. Prischak
No Relationships to Disclose
 
Hatcher J. Ballard
No Relationships to Disclose
 
Adam N. Duca
No Relationships to Disclose
 
James M. Gerson
Consulting or Advisory Role - Abbvie; Kite, a Gilead Company; Pharmacyclics; TG Therapeutics
 
Daniel J Landsburg
Consulting or Advisory Role - ADC Therapeutics; Epizyme; Incyte; Karyopharm Therapeutics; MorphoSys
Speakers' Bureau - Seagen
Research Funding - Curis (Inst); Takeda (Inst); Triphase Accelerator Corp (Inst)
Other Relationship - Karyopharm Therapeutics
 
Stefan K. Barta
Honoraria - Acrotech Biopharma; Affimed Therapeutics; Daiichi Sankyo/Lilly; Kyowa Kirin International; Seagen
 
Jakub Svoboda
Consulting or Advisory Role - Adaptive Biotechnologies; ADC Therapeutics; AstraZeneca; Atara Biotherapeutics; BMS; Pharmacyclics; Seagen
Research Funding - Adaptive Biotechnologies (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca